Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-11-14
2006-11-14
Shameem, Golam M. M. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S524000, C514S579000, C514S602000, C514S603000, C514S438000, C546S251000, C549S075000, C558S413000, C564S083000, C564S087000
Reexamination Certificate
active
07135487
ABSTRACT:
The present invention relates to novel sulphonamide derivatives, to processes for their preparation and to pharmaceutical compositions containing them.
REFERENCES:
patent: 2193015 (1940-03-01), Weissberger
patent: 2548574 (1951-04-01), Weissberger, I et al.
patent: 2552241 (1951-05-01), Weissberger, II et al.
patent: 2618656 (1952-11-01), Thirtle et al.
patent: 2652428 (1953-09-01), Weissberger, III et al.
patent: 3143549 (1964-08-01), Lafferty et al.
patent: 3267139 (1966-08-01), Lafferty
patent: 3629332 (1971-12-01), Harrington et al.
patent: 3860723 (1975-01-01), Baile et al.
patent: 4210749 (1980-07-01), Shetty
patent: 4258058 (1981-03-01), Witte, I et al.
patent: 4401663 (1983-08-01), Buckwalter et al.
patent: 4443477 (1984-04-01), Witte, II et al.
patent: 4563188 (1986-01-01), Bugaut et al.
patent: 4863905 (1989-09-01), Hudspeth et al.
patent: 4866196 (1989-09-01), Iwakuma et al.
patent: 4948809 (1990-08-01), Witte et al.
patent: 4948810 (1990-08-01), Iwakuma et al.
patent: 4971620 (1990-11-01), Jikihara et al.
patent: 4981873 (1991-01-01), Witte et al.
patent: 5476846 (1995-12-01), Lardy et al.
patent: 5521219 (1996-05-01), Vazquez et al.
patent: 5585519 (1996-12-01), Zeller
patent: 6174922 (2001-01-01), Arnold et al.
patent: 6303816 (2001-10-01), Arnold et al.
patent: 6310095 (2001-10-01), Sebti et al.
patent: 6355655 (2002-03-01), Escribano et al.
patent: 6358981 (2002-03-01), Arnold et al.
patent: 6358982 (2002-03-01), Cantrell et al.
patent: 6387954 (2002-05-01), Jones et al.
patent: 6596716 (2003-07-01), McKennon et al.
patent: 640160 (1964-05-01), None
patent: DE-1240853 (1967-05-01), None
patent: 0255728 (1987-08-01), None
patent: 0325245 (1989-01-01), None
patent: 0326170 (1989-01-01), None
patent: 0427449 (1991-07-01), None
patent: 0657422 (1995-06-01), None
patent: 0 501 322 (1996-09-01), None
patent: 0811375 (1997-10-01), None
patent: 0 665 442 (2001-05-01), None
patent: 1006887 (1965-10-01), None
patent: 1059360 (1967-02-01), None
patent: 204029 (1990-04-01), None
patent: 49-29179 (1974-08-01), None
patent: 49/29179 (1974-08-01), None
patent: 53124279 (1978-10-01), None
patent: 01175962 (1989-07-01), None
patent: 02/72150 (1990-03-01), None
patent: 2-72150 (1990-03-01), None
patent: 04049230 (1992-02-01), None
patent: 92-08696 (1992-05-01), None
patent: WO 92/08696 (1992-05-01), None
patent: WO 93/14745 (1993-08-01), None
patent: WO-94/27947 (1994-12-01), None
patent: WO-96/05818 (1996-02-01), None
patent: WO 97/08155 (1997-03-01), None
patent: WO-00/06083 (2000-02-01), None
patent: WO-00/06148 (2000-02-01), None
patent: WO-00/06149 (2000-02-01), None
patent: WO-00/06156 (2000-02-01), None
patent: WO-00/06176 (2000-02-01), None
patent: WO-00/06537 (2000-02-01), None
patent: WO-00/66546 (2000-11-01), None
patent: 60/294514 (2001-05-01), None
patent: WO-01/42203 (2001-06-01), None
patent: WO-01/68592 (2001-09-01), None
patent: WO-01/90055 (2001-11-01), None
patent: WO-01/90056 (2001-11-01), None
patent: WO-01/90057 (2001-11-01), None
patent: WO-01/96289 (2001-12-01), None
patent: WO-02/14275 (2002-02-01), None
patent: WO-02/14294 (2002-02-01), None
patent: WO-02/18329 (2002-03-01), None
patent: WO-02/32858 (2002-04-01), None
patent: WO 02/098846 (2002-12-01), None
patent: WO 02/098847 (2002-12-01), None
RN: 33893-36-6; RN:216237-08-0; RN:36458-15-8; RN:24954-60-7.
U.S. Appl. No. 60/296,008, pending.
U.S. Appl. No. 60/294,428, pending.
Partin et al., Neuron., 1993, pp. 1069-1082, 11.
Foye et al., J. Pharm. Sci., 1971, pp. 1095-1096.
Gaultieri et al., J. Pharm. Sci., 1973, pp. 849-851, 62(5).
Foye et al., J. Pharm. Sci., 1979, pp. 591-595, 68(5).
Foye et al., J. Pharm. Sci., 1977, pp. 923-926, 66(7).
Desos et al., Bioorg. & Med. Chem. Let., 1996, pp. 3003-3008, 6(24).
Sekiguchi et al., J. Neuroscience, 1997, pp. 5760-5771, 17(15).
Sekiguchi et al., Brit. J. of Pharmacol., 1998, pp. 1294-1303, 123.
Kozikowski et al., J. Org. Chem., 1979, pp. 2788-2790, 44(15).
Toshimitsu et al., J. Chem. Soc. Perkin Trans. 1, 1994, pp. 3465-3471, 23.
Hamana et al., Yakugaku Zasshi, 1970, pp. 991-1000, 90(8) and Chem. Abstracts, 1970, 73(25), Abstract No. 130926z.
Rawal et al., Tetrahedron Let., 1991, pp. 1695-1698, 32(14).
Das et al., Indian J. Chem., 1974, pp. 1139-1140, 12(11).
Deyrup et al., Tetrahedron Let., 1973, pp. 4771-4773, 48.
Rao et al., Biochem. Pharmacol., 1986, pp. 1925-1928, 35(12).
Heuvel, Vanden et al., Anal. Chem., 1964, pp. 1550-1560, 36(8).
Arnold Macklin B
Baker Stephen R
Bleisch Thomas J
Cantrell Buddy E
Escribano Ana M
Eli Lilly and Company
Hostettler Danica
Lentz Nelsen L.
Sackey Ebenezer
Shameem Golam M. M.
LandOfFree
Sulphonamide derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sulphonamide derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sulphonamide derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3621126